Adicet Non Currrent Assets Other vs Total Assets Analysis

ACET Stock  USD 1.01  0.09  8.18%   
Adicet Bio financial indicator trend analysis is way more than just evaluating Adicet Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adicet Bio is a good investment. Please check the relationship between Adicet Bio Non Currrent Assets Other and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Non Currrent Assets Other vs Total Assets

Non Currrent Assets Other vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adicet Bio Non Currrent Assets Other account and Total Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Adicet Bio's Non Currrent Assets Other and Total Assets is 0.43. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Total Assets in the same time period over historical financial statements of Adicet Bio, assuming nothing else is changed. The correlation between historical values of Adicet Bio's Non Currrent Assets Other and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Adicet Bio are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Currrent Assets Other i.e., Adicet Bio's Non Currrent Assets Other and Total Assets go up and down completely randomly.

Correlation Coefficient

0.43
Relationship DirectionPositive 
Relationship StrengthWeak

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Total Assets

Total assets refers to the total amount of Adicet Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Adicet Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Adicet Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adicet Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.At this time, Adicet Bio's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is expected to grow at the current pace this year, despite the fact that Enterprise Value is likely to grow to (54.6 M).
 2021 2022 2023 2024 (projected)
Interest Expense176K80K25K23.8K
Depreciation And Amortization4.1M5.0M6.1M5.2M

Adicet Bio fundamental ratios Correlations

-0.130.870.810.410.1-0.47-0.160.490.720.140.93-0.01-0.090.19-0.47-0.270.390.130.110.760.96-0.030.690.290.43
-0.13-0.090.020.12-0.46-0.310.80.270.0-0.260.01-0.330.96-0.1-0.130.840.65-0.15-0.420.11-0.220.940.00.82-0.88
0.87-0.090.960.69-0.17-0.510.130.650.89-0.30.92-0.45-0.08-0.06-0.35-0.250.520.22-0.190.890.750.020.870.370.44
0.810.020.960.69-0.34-0.60.270.790.97-0.390.86-0.550.04-0.15-0.38-0.150.680.33-0.360.90.70.140.960.510.32
0.410.120.690.69-0.38-0.510.440.50.69-0.640.53-0.720.11-0.01-0.12-0.10.590.25-0.250.590.290.240.70.50.09
0.1-0.46-0.17-0.34-0.380.11-0.82-0.78-0.430.79-0.030.72-0.440.52-0.4-0.35-0.59-0.280.92-0.380.19-0.44-0.45-0.560.27
-0.47-0.31-0.51-0.6-0.510.11-0.24-0.41-0.640.08-0.430.31-0.37-0.290.630.06-0.77-0.260.01-0.37-0.47-0.49-0.64-0.630.24
-0.160.80.130.270.44-0.82-0.240.590.3-0.770.08-0.780.75-0.420.140.670.720.02-0.80.35-0.310.770.310.78-0.6
0.490.270.650.790.5-0.78-0.410.590.84-0.590.57-0.670.3-0.45-0.060.170.770.37-0.780.750.380.350.850.650.03
0.720.00.890.970.69-0.43-0.640.30.84-0.440.75-0.60.03-0.18-0.35-0.180.710.48-0.430.830.630.140.990.510.29
0.14-0.26-0.3-0.39-0.640.790.08-0.77-0.59-0.44-0.110.94-0.20.58-0.35-0.2-0.46-0.160.78-0.410.31-0.26-0.46-0.390.07
0.930.010.920.860.53-0.03-0.430.080.570.75-0.11-0.270.03-0.02-0.43-0.070.48-0.02-0.090.860.80.10.730.390.35
-0.01-0.33-0.45-0.55-0.720.720.31-0.78-0.67-0.60.94-0.27-0.280.58-0.02-0.27-0.64-0.250.76-0.530.17-0.37-0.63-0.540.11
-0.090.96-0.080.040.11-0.44-0.370.750.30.03-0.20.03-0.28-0.04-0.140.830.7-0.17-0.370.03-0.160.990.030.85-0.91
0.19-0.1-0.06-0.15-0.010.52-0.29-0.42-0.45-0.180.58-0.020.58-0.04-0.12-0.39-0.13-0.160.74-0.260.33-0.03-0.2-0.09-0.05
-0.47-0.13-0.35-0.38-0.12-0.40.630.14-0.06-0.35-0.35-0.43-0.02-0.14-0.12-0.11-0.39-0.21-0.26-0.24-0.46-0.23-0.35-0.320.08
-0.270.84-0.25-0.15-0.1-0.350.060.670.17-0.18-0.2-0.07-0.270.83-0.39-0.110.41-0.17-0.45-0.04-0.380.78-0.170.62-0.78
0.390.650.520.680.59-0.59-0.770.720.770.71-0.460.48-0.640.7-0.13-0.390.410.27-0.540.550.280.780.720.94-0.45
0.13-0.150.220.330.25-0.28-0.260.020.370.48-0.16-0.02-0.25-0.17-0.16-0.21-0.170.27-0.230.170.22-0.110.460.160.16
0.11-0.42-0.19-0.36-0.250.920.01-0.8-0.78-0.430.78-0.090.76-0.370.74-0.26-0.45-0.54-0.23-0.450.24-0.38-0.45-0.490.19
0.760.110.890.90.59-0.38-0.370.350.750.83-0.410.86-0.530.03-0.26-0.24-0.040.550.17-0.450.610.10.820.430.35
0.96-0.220.750.70.290.19-0.47-0.310.380.630.310.80.17-0.160.33-0.46-0.380.280.220.240.61-0.120.610.190.44
-0.030.940.020.140.24-0.44-0.490.770.350.14-0.260.1-0.370.99-0.03-0.230.780.78-0.11-0.380.1-0.120.140.9-0.88
0.690.00.870.960.7-0.45-0.640.310.850.99-0.460.73-0.630.03-0.2-0.35-0.170.720.46-0.450.820.610.140.510.29
0.290.820.370.510.5-0.56-0.630.780.650.51-0.390.39-0.540.85-0.09-0.320.620.940.16-0.490.430.190.90.51-0.63
0.43-0.880.440.320.090.270.24-0.60.030.290.070.350.11-0.91-0.050.08-0.78-0.450.160.190.350.44-0.880.29-0.63
Click cells to compare fundamentals

Adicet Bio Account Relationship Matchups

Adicet Bio fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets81.6M153.8M338.9M330.7M207.3M215.3M
Short Long Term Debt Total114.1M21.6M20.9M21.0M20.9M19.9M
Other Current Liab2.8M4.5M5.1M10.3M10.2M18.3M
Total Current Liabilities14.9M14.0M16.3M19.7M19.3M18.3M
Total Stockholder Equity(60.4M)(106.3M)(168.3M)(238.1M)170.2M178.7M
Property Plant And Equipment Net2.1M25.9M35.0M49.0M44.2M46.4M
Net Debt103.5M(62.7M)(256.6M)(236.6M)(138.8M)(131.8M)
Retained Earnings(69.6M)(106.3M)(168.3M)(238.1M)(380.8M)(361.7M)
Accounts Payable1.1M1.6M3.3M4.4M2.6M2.5M
Cash10.6M84.3M277.5M257.7M159.7M83.6M
Non Current Assets Total17.4M59.2M56.5M69.7M45.0M58.4M
Cash And Short Term Investments62.4M94.6M277.5M257.7M159.7M95.6M
Common Stock Shares Outstanding15.0M7.3M31.0M41.1M43.0M28.0M
Liabilities And Stockholders Equity81.6M153.8M(132.5M)(199.8M)207.3M165.2M
Non Current Liabilities Total127.1M246.2M19.5M18.6M17.8M16.9M
Other Current Assets179K5.6M4.7M2.9M2.6M2.4M
Other Stockholder Equity(106.7M)62.3M471.4M530.4M550.9M578.5M
Total Liab142.0M44.0M35.8M38.4M37.1M35.3M
Total Current Assets64.2M94.6M282.4M261.0M162.3M156.9M
Accumulated Other Comprehensive Income(5.1M)(41K)23K24K(338.9M)0.0
Common Stock1K3K4K2K3.6K3.4K
Non Currrent Assets Other4.7M12.1M2.0M1.2M822K863.1K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.